Global Hemostats Market to reach USD 3.76 Billion by 2027.Global Hemostats Market is valued approximately at USD 2.47 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2021-2027. A hemostat is a kind of surgical tool which is used in many surgical procedures in order to control bleeding. The global Hemostats market is being driven by growing volume of surgical procedures performed, increasing incidence of sports-related injuries and spinal ailments and rising focus on R&D. Furthermore, growth in the number of hospitals & surgical center and growing adoption of advanced hemostats in emerging markets will provide new opportunities for the global Hemostats industry. For instance, according to the data of Commonwealth Fund in year 2018, China has around 12,000 public hospitals and 21,000 private hospitals. Also, in June year 2019, the Indian Ministry of Health and Family Welfare had announced the opening of around 22 new AIIMS across the country. Additionally, in year 2020 October, the Prime Minister of the UK has announced the plans for investing USD 4.3 billion in 40 hospitals and also launch certain schemes for the future funding for 48 hospitals by 2030. Additionally, as per the report of WHO released in 2019, every year around 235 million major surgical procedures are being undertaken worldwide. As a result, increase in volume of surgical procedures performed will serve as a catalyst for the Hemostats industry in the future. However, side effects and allergic reactions associated with hemostats may impede market growth over the forecast period of 2021-2027.

Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key regions considered for the regional analysis of global Hemostats market. The growing geriatric population and the increasing number of surgeries performed makes the North America the leading region across the world in terms of market share. Whereas North America is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027 due to strong presence of major market players in the region.
Major market player included in this report are:

Becton, Dickinson & company (c. r. bard)
Baxter International, Inc.
Teleflex Incorporated
B. Braun Melsungen Ag
Johnson & Johnson (ethicon, Inc.)
Medtronic plc
Hemostasis, LLC
Pfizer INC.
Stryker
Cryolife, Inc.


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Thrombin-based hemostats
Oxidized regenerated cellulose-based hemostats
Combination Hemostats
Gelatin-based hemostats
Collagen-based hemostats
By Formulation:
Matrix & gel hemostats
Sheet & pad hemostats
Sponge hemostats
Powder hemostats
By Application:
Orthopaedic surgery
General surgery
Neurological surgery
Cardiovascular surgery
Reconstructive surgery
Gynaecological surgery
Other surgeries


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Hemostats Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors